[1]WANG Q, YANG F, MIAO Q, et al.The clinical phenotypes of autoimmune hepatitis:a comprehensive review[J].J Autoimmun, 2016, 66 (1) :98-107.
|
[2]WONG GW, YEONG T, LAWRENCE D, et al.Concurrent extrahepatic autoimmunity in autoimmune hepatitis:implications for diagnosis, clinical course and long-term outcomes[J].Liver Int, 2017, 37 (3) :449-457.
|
[3]WONG GW, HENEGHAM MA.Association of extrahepatic manifestations with autoimmune hepatitis[J].Dig Dis, 2015, 33 (Suppl2) :25-35.
|
[4]van GERVEN NM, VERWER BJ, WITTE BI, et al.Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands[J].Scand J Gastroenterol, 2014, 49 (10) :1245-1254.
|
[5]MURATORI P, LENZI M, CASSANI F, et al.Diagnostic approach to autoimmune hepatitis[J].Expert Rev Clin Immunol, 2017, 13 (8) :769-779.
|
[6]LIU JJ, ZHANG JX, LI J, et al.Clinical analysis of 39 cases of autoimmune hepatitis[J].Tianjin Med J, 2012, 40 (7) :732-734. (in Chinese) 刘均娟, 张俊霞, 李嘉.自身免疫性肝炎39例临床分析[J].天津医药, 2012, 40 (7) :732-734.
|
[7]TAO L, HUANG SJ, LI L, et al.Analysis of clinical features of 24patients with autoimmune hepatitis[J].J Guangxi Med Univ, 2014, 31 (3) :456-458. (in Chinese) 陶霖, 黄世江, 李莉, 等.自身免疫性肝炎24例临床特点分析[J].广西医科大学学报, 2014, 31 (3) :456-458.
|
[8]LI SQ, ZHOU L, ZHANG J, et al.Clinical characteristics of 96patients with autoimmune hepatitis[J].J Tianjin Med Univ, 2015, 21 (3) :239-242. (in Chinese) 李树倩, 周璐, 张洁, 等.96例自身免疫性肝炎患者的临床特征[J].天津医科大学学报, 2015, 21 (3) :239-242.
|
[9]LI XM, LUO F, MA X, et al.Clinical manifestations and pathological features of autoinnnune hepatitis[J].J Clin Intern Med, 2006, 23 (8) :525-528. (in Chinese) 李新民, 骆帆, 马雄, 等.自身免疫性肝炎的临床特点和病理分析[J].临床内科杂志, 2006, 23 (8) :525-528.
|
[10]FANG XF, LIN R, LUO LL, et al.Clinical features of patients with autoimmune hepatitis combined with extrahepatic autoimmune diseases[J].Shandong Med J, 2014, 54 (40) :75-77. (in Chinese) 范晓飞, 林睿, 罗莉丽, 等.自身免疫性肝炎合并肝外自身免疫疾病患者的临床特点观察[J].山东医药, 2014, 54 (40) :75-77.
|
[11]WANG WH, WU GD, XIONG CQ, et al.A case report of overlapping autoimmune hepatitis with multiple dermatomyositis[J].Chin Hepatol, 2014, 19 (3) :233. (in Chinese) 王文虎, 吴国栋, 熊昌清, 等.自身免疫性肝炎重叠多发性皮肌炎1例[J].肝脏, 2014, 19 (3) :233.
|
[12]LEUNG J, DOWLING L, OBADAN I, et al.Risk of non-melanoma skin cancer in autoimmune hepatitis[J].Dig Dis Sci, 2010, 55 (11) :3218-3223.
|
[13]WERNER M, ALMER S, PRYTZ H, et al.Hepatic and extrahepatic malignancies in autoimmune hepatitis.A long-term followup in 473 Swedish patients[J].J Hepatol, 2009, 50 (2) :388-393.
|
[14]JENSEN P, EGEBERG A, GISLASON G, et al.Increased risk of autoimmune hepatitis in patients with psoriasis:a Danish Nationwide Cohort Study[J].J Invest Dermatol, 2016, 136 (7) :1515-1517.
|
[15]ZACHOU K, GATSELIS NK, ARVANITI P, et al.A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis[J].Aliment Pharmacol Ther, 2016, 43 (10) :1035-1047.
|
[16]ABE M, MASHIBA T, ZENIYA M, et al.Present status of autoimmune hepatitis in Japan:a nationwide survey[J].J Gastroenterol, 2011, 46 (9) :1136-1141.
|
[17]AL-CHALABI T, BOCCATO S, PORTMANN BC, et al.Autoimmune hepatitis (AIH) in the elderly:a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre[J].J Hepatol, 2006, 45 (4) :575-583.
|
[18]CHOUDHURI G, SOMANI SK, BADA CS, et al.Autoimmune hepatitis in India:profile of an uncommon disease[J].BMC Gastroenterol, 2005, 5:27.
|
[19]AMARAPURKAR DN, PATEL ND.Spectrumof autoimmune liver diseases in western India[J].J Gastroenterol Hepatol, 2007, 22 (12) :2112-2117.
|
[20]MURATORI P, FABBRI A, LALANNE C, et al.Autoimmune liver disease and concomitant extrahepatic autoimmune disease[J].Eur J Gastroenterol Hepatol, 2015, 27 (10) :1175-1179.
|
[21]BITTENCOURT PL, FARIAS AQ, PORTA G, et al.Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis:effect of age, gender, and genetic background[J].J Clin Gastroenterol, 2008, 42 (30) :300-305.
|
[22]KAVEHMANESH Z, BEIRAGHDARR F, SABURI A, et al.Pediatric autoimmune hepatitis in a patient who presented with erythema nodosum:a case report[J].Hepat Mon, 2012, 12 (1) :42-45.
|
[23]XENOPHONTOS E, IOANNOU A, CONSTANTINIDES T, et al.Sweet syndrome on a patient with autoimmune hepatitis on azathioprine and CMV infection[J].Oxf Med Case Rep, 2016, 2016 (2) :24-27.
|
[24]MENDEZ-FLORES S, CHARLI-JOSEPH Y, SAEB-LIMA M, et al.Amicrobial pustulosis of the folds associated with autoimmune disorders:systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis[J].Dermatology, 2013, 226 (1) :1-4.
|
[25]DANTAS SG, QUINTELLA LP, FERNANDES NC.Exuberant pyoderma gangrenosum in a patient with autoimmune hepatitis[J].An Bras Dermatol, 2017, 92 (1) :114-117.
|
[26]POWELL FC, SCHROETER AL, WP S, et al.Pyoderma gangrenosum:a review of 86 patients[J].Q J Med, 1985, 55 (217) :173-186.
|
[27]BINUS AM, QURESHI AA, LI VW, et al.Pyoderma gangrenosum:a retrospective review of patient characteristics, comorbidities and therapy in 103 patients[J].Br J Dermatol, 2011, 165 (6) :1244-1250.
|
[28]CARD TR, LANGAN SM, CHU TP.Extra-gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported[J].Dig Dis Sci, 2016, 61 (9) :2619-2626.
|
[29]CZAJA AJ.Autoantibodies as prognostic markers in autoimmune liver disease[J].Dig Dis Sci, 2010, 55 (8) :2144-2161.
|
[30]ZHAO Y, YAN HP, TAN YF, et al.Significance of antibody double-stranded DNA in autoimmune hepatitis[J].Chin J Microbiol Immunol, 2008, 28 (7) :639-642. (in Chinese) 赵艳, 闫惠平, 檀玉芬, 等.ds DNA抗体检测对自身免疫性肝炎的临床意义[J].中华微生物学和免疫学杂志, 2008, 28 (7) :639-642.
|
[31]SUN LM, YAN HP, FENG X, et al.Antibody to R052 in patients with type I autoimmune hepatitis[J].Chin J Lab Diagn, 2014, 18 (2) :236-239. (in Chinese) 孙丽梅, 闫惠平, 冯霞, 等.I型自身免疫性肝炎患者抗R052抗体的检测及临床意义[J].中国实验诊断学, 2014, 18 (2) :236-239.
|
[32]KONG XS, YAN HP, LIAO HY, et al.Detection of anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis[J].Beijing Med J, 2010, 32 (12) :947-950. (in Chinese) 孔祥沙, 闫惠平, 廖慧钰, 等.抗中性粒细胞胞浆抗体对自身免疫性肝炎的检测意义[J].北京医学, 2010, 32 (12) :947-950.
|
[33] FLOREANI A, FRANCESCHET I, CAZZAGON N, et al.Extrahepatic autoimmune conditions associated with primary biliary cirrhosis[J].Clin Rev Allergy Immunol, 2015, 48 (2-3) :192-197.
|
[34]MILLS P, MACSWEEN RN, WATKINSON G.Arthritis and primary biliary cirrhosis[J].Br Med J, 1977, 2 (6096) :1224.
|
[35] GU EL, YAO GB.The clinical characteristics of primary biliary cirrhosis in China:a sysfimafic review[J].Chin J Hepatol, 2009, 17 (11) :861-866. (in Chinese) 顾而立, 姚光弼.中国人原发性胆汁性肝硬化的临床特点:52年文献的系统分析[J].中华肝脏病杂志, 2009, 17 (11) :861-866.
|
[36]LIU SL, YANG Z, HU QM, et al.Primary biliary cirrhosis associated with primary Sjogren’s syndrome:a case report and literature review[J].J Clin Hepatol, 2015, 31 (10) :1718-1721. (in Chinese) 刘沙利, 杨政, 胡勤明, 等.原发性胆汁性肝硬化合并原发性干燥综合征1例报告并文献复习[J].临床肝胆病杂志, 2015, 31 (10) :1718-1721.
|
[37]KUNG YY, TSAI CY, TSAI YY, et al.Enthesopathy in a case of primary biliary cirrhosis with positive HLA-B27[J].Clin Exp Rheumatol, 1997, 15 (6) :708-709.
|
[38]MAEDA MH, TSUJI S, SHIMIZU J.Inflammatory myopathies associated with antimitochondrial antibodies[J].Brain, 2012, 135 (6) :1767-1777.
|
[39]TSIANOS EV, HOOFNAGLE JH, FOX PC, et al.Sjogren’s syndrome in patients with primary biliary cirrhosis[J].Hepatology, 1990, 11 (5) :730-734.
|
[40]LIBERAL R, GRANT CR, SAKKAS L, et al.Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis[J].Clin Res Hepatol Gastroenterol, 2013, 37 (6) :572-585.
|
[41]LIU RR, LI MT, FEl YY, et al.Clinical features of primary binary cirrhosis associated with systemic sclerosis[J].Chin J Rheumatol, 2010, 14 (11) :746-749. (in Chinese) 刘润荣, 李梦涛, 费允云, 等.系统性硬化病合并原发性胆汁性肝硬化的临床分析及文献复习[J].中华风湿病学杂志, 2010, 14 (11) :746-749.
|
[42]WANG L, GAO LX, ZHANG FC.Primary binary cirrhosis associatied with polymyositis[J].Chin J Rheumatol, 2011, 15 (3) :172-174. (in Chinese) 王立, 高丽霞, 张奉春.多发性肌炎合并原发性胆汁性肝硬化十例临床分析[J].中华风湿病学杂志, 2011, 15 (3) :172-174.
|
[43]SUN HY, WU B, CHEN LY, et al.Primary sjogren syndrome associated with antiphospholipid syndrome and primary biliary cirrhosis:a case report[J].Chin Mod Doctor, 2007, 45 (19) :144-145. (in Chinese) 孙华瑜, 巫斌, 陈莉滢, 等.原发性干燥综合征伴抗磷脂综合征和原发性胆汁性肝硬化1例[J].中国现代医生, 2007, 45 (19) :144-145.
|
[44]LI L, LIU XM, ZHAO XG.Primary binary cirrhosis with retroperitoneal fibrosis:a case report[J].J Pract Med, 2011, 27 (16) :3094. (in Chinese) 李丽, 刘晓敏, 赵学刚.原发性胆汁性肝硬化合并腹膜后纤维化1例[J].实用医学杂志, 2011, 27 (16) :3094.
|
[45]LEI JJ, ZHOU L, CHEN J.Primary biliary cirrhosis complicated with sarcoidosis:one-case analysis[J].World Chin J Dig, 2009, 17 (1) :106-108. (in Chinese) 雷静静, 周力, 陈佳.原发性胆汁性肝硬化并结节病1例[J].世界华人消化杂志, 2009, 17 (1) :106-108.
|
[46]WANG SX, PU J, CUI LH.A case of primary biliary cirrhosis complicated with Castleman disease[J].Natl Med J China, 2011, 91 (20) :1440. (in Chinese) 王少鑫, 浦江, 崔立红.原发性胆汁性肝硬化合并Castleman病一例[J].中华医学杂志, 2011, 91 (20) :1440.
|
[47]TERZIROLI BERETTA-PICCOLI B, GUILLOD C, MARSTELLER I, et al.Primary biliary cholangitis associated with skin disorders:a case report and review of the literature[J].Arch Immunol Ther Exp (Warsz) , 2017, 65 (4) :299-309.
|
[48]MARZANO AV, RAMONI S, CAPUTO R.Amicrobial pustulosis of the folds.Report of 6 cases and a literature review[J].Dermatology, 2008, 216 (4) :305-311.
|
[49]CORPECHOT C, CHRETIEN Y, CHAZOUILLERES O, et al.Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis[J].J Hepatol, 2010, 53 (1) :162-169.
|
[50]PRINCE MI, DUCKER SJ, JAMES OF.Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations[J].Gut, 2010, 59 (4) :508-512.
|
[51]GERSHWIN ME, SELMI C, WORMAN HJ, et al.Risk factors and comorbidities in primary biliary cirrhosis:a controlled interviewbased study of 1032 patients[J].Hepatology, 2005, 42 (5) :1194-1202.
|
[52]HUANG FL, DIAO MY, QIN BD, et al.Meta-analysis of diagnostic value of anti-GP210 antibody detection in Chinese population for primary biliary cirrhosis[J].Int J Lab Med, 2013, 34 (12) :1508-1510. (in Chinese) 黄凤楼, 刁孟元, 秦保东, 等.抗GP210抗体检测对中国人群原发性胆汁性肝硬化诊断价值的meta分析[J].国际检验医学杂志, 2013, 34 (12) :1508-1510.
|
[53]CHAN HL, LEE YS, HONG HS, et al.Anticentromere antibodies (ACA) :clinical dis-tribution and disease specificity[J].Clin Exp Dermatol, 1994, 19 (4) :298-302.
|
[54] LIBERAL R, GRANT CR, SAKKAS L, et al.Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis[J].Clin Res Hepatol Gastroenterol, 2013, 37 (6) :572-585.
|
[55]GUILLN-DEL CASTILLO A, CALLEJAS-MORAGA EL, GARCA G, et al.High sensitivity and negative predictive value of the DETECTalgorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis:application in a single center[J].Arthritis Res Ther, 2017, 19 (1) :135.
|
[56]SHI XH, ZHANG FC, ZHANG X.Significance of anticentromere antibody in primary biliary cirrhosis[J].Chin J Rheumatol, 2006, 10 (8) :485-487. (in Chinese) 史旭华, 张奉春, 张炬.抗着丝点抗体在原发性胆汁性肝硬化中的意义[J].中华风湿病学杂志, 2006, 10 (8) :485-487.
|
[57]SHEN M, ZHANG X, ZHANG FC.Primary biliary cirrhosis complicated by pulmonary arterial hypertension:a clinical analysis[J].Natl Med J China, 2005, 85 (14) :946-948. (in Chinese) 沈敏, 张烜, 张奉春.原发性胆汁性肝硬化合并肺动脉高压的临床分析[J].中华医学杂志, 2005, 85 (14) :946-948.
|
[58]FLOREANI A, FRANCESCHET I, CAZZAGON N, et al.Extrahepatic autoimmune conditions associated with primary biliary cirrhosis[J].Clin Rev Allergy Immunol, 2015, 48 (2-3) :192-197.
|
[59]AGMON-LEVIN N, SHAPIRA Y, SELMI C, et al.A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis[J].J Autoimmun, 2010, 34 (1) :55-58.
|
[60]von LANDENBERG P, BAUMGARTHER M, SCHOELMERICH J, et al.Clinical relevance of antiphospholipid antibodies in primary biliary cirrhosis[J].Ann N Y Acad Sci, 2005, 1051 (1) :20-28.
|
[61]CIESEK S, BECKER T, MANNS MP, et al.Anti-parietal cell autoantibodies (PCA) in primary biliary cirrhosis:a putative m arker for recurrence after orthotopic liver transplantation?[J].Ann Hepatol, 2010, 9 (2) :181.
|
[62]PALMELA C, PEERANI F, CASTANEDA D, et al.Inflammatory bowel disease and primary sclerosing cholangitis:a review of the phenotype and associated specific features[J].Gut Liver, 2018, 12 (1) :17-29.
|
[63]XU X, SU L, GAO Y, et al.The prevalence of nonalcoholic fatty liver disease and related metabolic comorbidities was associated with age at onset of moderate to severe plaque psoriasis:a cross-sectional study[J].PLo S One, 2017, 12 (1) :e0169952.
|
[64]CHIBA M, TOBORI F, YAGISAWA H, et al.A Japanese case of ulcerative colitis associated with dermatitis herpetiformis and primary sclerosing cholangitis[J].Inflamm Bowel Dis, 1996, 2 (5) :255-259.
|
[65]RUPP C, MUMMELTHEI A, SAUER P, et al.Non-IBD immunological diseases are a risk factor for reduced survival in PSC[J].Liver Int, 2013, 33 (1) :86-93.
|